LENSAR (LNSR) Financials: History & Chart

LENSAR Inc(LNSR)

Medical - Devices · Orlando, FL

$6.78+0.11 (+1.57%)

Delayed quote: Oct 6, 2026, 12:31 PM EDT

About LENSAR Inc

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.

Orlando, FL

150 employees

www.lensar.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Nicholas T. Curtis

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	60.26M	16.50M	13.43M	16.02M	14.32M	13.94M	14.16M	16.73M	13.54M
Cost of Goods Sold	31.36M	6.72M	7.05M	9.09M	8.51M	6.91M	7.03M	9.62M	7.27M
Gross Profit	28.90M	9.78M	6.38M	6.94M	5.81M	7.02M	7.13M	7.11M	6.27M
Gross Profit Margin	48.0%	59.3%	47.5%	43.3%	40.6%	50.4%	50.3%	42.5%	46.3%
Total Operating Expenses	37.03M	7.64M	4.14M	11.86M	13.39M	13.31M	12.91M	8.40M	7.28M
Research & Development	5.32M	1.27M	1.39M	1.30M	1.37M	1.43M	1.53M	1.33M	1.20M
Selling, General & Administrative	31.02M	6.14M	2.53M	10.33M	12.02M	11.66M	11.15M	6.83M	6.08M
Operating Income (EBIT)	-8.13M	2.13M	2.24M	-4.92M	-7.58M	-6.29M	-5.79M	-1.29M	-1.01M
Operating Margin	-13.5%	12.9%	16.7%	-30.7%	-52.9%	-45.1%	-40.9%	-7.7%	-7.5%
Income Before Tax (EBT)	34.70M	3.54M	36.33M	-1.46M	-3.71M	-1.76M	-27.34M	-18.70M	-1.50M
Interest Income	40K	17K	N/A	23K	N/A	22K	26K	23K	25K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Other Income/Expense	42.82M	1.40M	34.09M	3.46M	3.87M	4.53M	-21.55M	-17.41M	-489K
Net Income	34.70M	3.54M	36.33M	-1.46M	-3.71M	-1.76M	-27.34M	-18.70M	-1.50M
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit Margin	57.6%	21.4%	270.6%	-9.1%	-25.9%	-12.7%	-193.1%	-111.8%	-11.1%
EBITDA	-4.43M	2.36M	3.37M	-3.75M	-6.42M	-5.19M	-4.71M	-184K	-7K
EBITDA Margin	-7.4%	14.3%	25.1%	-23.4%	-44.9%	-37.3%	-33.3%	-1.1%	-0.1%
Depreciation & Amortization	3.69M	228K	1.13M	1.17M	1.16M	1.09M	1.08M	1.11M	1.01M
EPS Basic	N/A	0.14	N/A	-0.12	-0.31	-0.15	-2.32	-1.61	-0.13
EPS Diluted	N/A	0.10	N/A	-0.12	-0.31	-0.15	-2.32	-1.61	-0.13
Weighted Average Basic Shares	12.30M	12.30M	12.16M	12.07M	12.04M	11.94M	11.77M	11.63M	11.60M
Weighted Average Diluted Shares	23.03M	23.03M	15.42M	12.07M	12.04M	11.94M	11.77M	11.63M	11.60M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	58.44M	53.49M	42.16M	35.36M	34.46M	26.38M	30.53M	24.39M
Cost of Goods Sold	31.31M	27.64M	21.06M	15.40M	16.63M	12.31M	17.30M	14.78M
Gross Profit	27.12M	25.85M	21.11M	19.95M	17.83M	14.07M	13.23M	9.61M
Gross Profit Margin	46.4%	48.3%	50.1%	56.4%	51.8%	53.4%	43.3%	39.4%
Total Operating Expenses	51.70M	36.52M	33.34M	40.13M	37.48M	32.58M	25.94M	18.93M
Research & Development	5.62M	5.33M	6.14M	11.81M	12.36M	7.55M	7.57M	2.78M
Selling, General & Administrative	45.16M	26.49M	26.10M	27.17M	23.89M	23.77M	17.15M	16.14M
Operating Income (EBIT)	-24.58M	-10.66M	-12.23M	-20.18M	-19.65M	-18.50M	-12.71M	-9.32M
Operating Margin	-42.1%	-19.9%	-29.0%	-57.1%	-57.0%	-70.1%	-41.6%	-38.2%
Income Before Tax (EBT)	-34.28M	-31.40M	-14.38M	-19.91M	-19.60M	-19.77M	-14.66M	-12.57M
Interest Income	91K	103K	85K	17K	34K	N/A	N/A	3.27M
Interest Expense	N/A	N/A	N/A	N/A	N/A	1.34M	2.00M	N/A
Other Income/Expense	-9.70M	-20.74M	-2.15M	263K	51K	-1.27M	-1.94M	-3.26M
Net Income	-34.28M	-31.40M	-14.38M	-19.91M	-19.60M	-19.77M	-14.66M	-12.59M
Income Tax Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	20K
Net Profit Margin	-58.7%	-58.7%	-34.1%	-56.3%	-56.9%	-75.0%	-48.0%	-51.6%
EBITDA	-20.08M	-6.73M	-8.71M	-16.77M	-16.89M	-15.43M	-8.85M	-4.73M
EBITDA Margin	-34.4%	-12.6%	-20.7%	-47.4%	-49.0%	-58.5%	-29.0%	-19.4%
Depreciation & Amortization	4.50M	3.93M	3.52M	3.41M	2.76M	3.07M	3.87M	4.59M
EPS Basic	-2.87	-2.73	-1.31	-1.96	-2.10	-1.81	-1.57	-11.77
EPS Diluted	-2.87	-2.73	-1.31	-1.96	-2.10	-1.81	-1.57	-11.77
Weighted Average Basic Shares	11.96M	11.52M	10.97M	10.16M	9.37M	10.93M	10.64M	1.07M
Weighted Average Diluted Shares	11.96M	11.52M	10.97M	10.16M	9.37M	10.93M	10.64M	1.07M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.